MedTrace Logo

Pharmacokinetics of Procaterol in Elite Athletes

NCT05749536 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-03-01

No results posted yet for this study

Summary

The purpose of the study is to find blood and urine concentrations of procaterol administrated either by inhalation or by tablets in asthmatic and non-asthmatics males. We hypotheis that the concentrations of procaterol in the blood and serum is higher after tablet intake versus inhalation.

Conditions

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Vibeke Backer, MD · Bispebjerg Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05749536 on ClinicalTrials.gov